Orris

Calcium channel blocker combination antihypertensive

Reading File
Finding Sources
Finding Sources
Searching PubMed

"Hypertension"[MeSH Terms] AND "Calcium Channel Blockers"[MeSH Terms]

Searching the Web

2024 ESC hypertension guideline calcium channel blocker combination ACE inhibitor ARB beta blocker

Reading File
Reading File
Reading Web Page

https://pmc.ncbi.nlm.nih.gov/articles/PMC12011322

For primary hypertension, the preferred calcium channel blocker combination is usually:
  • Dihydropyridine CCB + ACE inhibitor: e.g., amlodipine + perindopril/lisinopril
  • Dihydropyridine CCB + ARB: e.g., amlodipine + telmisartan/losartan/valsartan
This pairing is effective because the CCB lowers vascular resistance, while ACE inhibitor or ARB suppresses the renin-angiotensin system. ACE inhibitor/ARB therapy can also reduce the ankle edema commonly caused by amlodipine.
If BP remains uncontrolled:
  • ACE inhibitor or ARB + dihydropyridine CCB + thiazide/thiazide-like diuretic, ideally as a single-pill combination when available.
Beta-blocker combinations
  • Add a beta-blocker to a CCB regimen mainly when there is another indication such as angina, prior myocardial infarction, HFrEF, or atrial fibrillation.
  • Avoid or use specialist supervision with verapamil or diltiazem + beta-blocker, as both slow heart rate and AV-node conduction, increasing risk of bradycardia, heart block, and worsening heart failure.
Avoid
  • ACE inhibitor + ARB together.
  • Combining two CCBs routinely unless a specialist has a specific reason.
For patients needing two drugs, ACE inhibitor plus amlodipine is supported as a first-line option; RAS blocker plus a CCB or a diuretic are preferred two-drug combinations. Textbook of Family Medicine 9e, Hypertension section, lines 3226-3233; Comprehensive Clinical Nephrology, 7th ed., p. 531. Current ESC guideline overview similarly favors ACE inhibitor/ARB with a dihydropyridine CCB or diuretic.

Patient on telma 80 and amlong 5mg is still having hypertension age is 65 yrs which other antihypertensive I can use

Reading File
Reading File
Finding Sources
Finding Sources
Searching PubMed

"Resistant Hypertension"[MeSH Terms] AND "Spironolactone"[MeSH Terms]

Searching the Web

2024 ESC Guidelines hypertension triple therapy ARB calcium channel blocker thiazide-like diuretic spironolactone renal monitoring

Reading File
Reading File
Finding Sources
Telmisartan 80 mg + amlodipine 5 mg is not yet maximal two-drug therapy, and this is not resistant hypertension yet.
A clinician would usually consider one of these next steps after confirming consistently high home BP:
  1. Increase amlodipine from 5 mg to 10 mg once daily
    • Useful if there is no troublesome ankle swelling, flushing, or dizziness.
  2. Add a thiazide-like diuretic, often preferred if BP remains clearly above target
    • Typical options: indapamide SR 1.5 mg once daily or chlorthalidone 12.5 mg once daily.
    • This creates the standard three-class regimen:
      ARB (telmisartan) + CCB (amlodipine) + thiazide-like diuretic.
Before adding a diuretic, the prescriber should check:
  • Serum creatinine/eGFR
  • Sodium and potassium
  • History of gout, low sodium, dehydration, or recurrent falls
  • Diabetes and other medicines, especially NSAID painkillers
Repeat renal function and electrolytes about 1 to 2 weeks after starting or increasing a diuretic, particularly at age 65 or with kidney disease.
Do not add an ACE inhibitor such as ramipril/enalapril to telmisartan. ACE inhibitor plus ARB increases kidney injury and hyperkalemia risk without routine benefit.
If BP remains high despite tolerated doses of telmisartan + amlodipine + a thiazide-like diuretic, then evaluate adherence, correct home BP technique, white-coat hypertension, high salt intake, NSAIDs/decongestants/steroids, kidney disease, sleep apnea, and other secondary causes. Only then is it considered resistant hypertension; low-dose spironolactone is commonly the next option, but requires close potassium and kidney-function monitoring.
A beta-blocker is generally not the routine next drug unless there is a reason such as angina, prior MI, atrial fibrillation, fast pulse, or heart failure.
Seek urgent care if BP is ≥180/120 mmHg and there is chest pain, breathlessness, weakness/numbness, confusion, severe headache, vision change, or reduced urine output.
Comprehensive Clinical Nephrology, 7th ed., p. 531-534: preferred escalation is RAS blocker + CCB + thiazide/thiazide-like diuretic; resistant hypertension is failure of this three-drug regimen at tolerated doses. Current 2024 ESC guideline summary also supports spironolactone only after uncontrolled triple therapy.
This is a shared conversation. Sign in to Orris to start your own chat.